发明名称 Piperidine derivatives in compounds that have a PDE4 inhibitory activity to treat inflammatory conditions
摘要 Piperidine derivatives represented by the following general formula (I) and non-toxic salts thereof are described. Because these derivatives have PDE4 inhibitory activity, the compounds represented by the general formula (I) are useful in preventing and/or treating conditions such as inflammatory diseases, diabetic diseases, allergic diseases, autoimmune diseases, osteoporosis, obesity, depression, Parkinson's disease, ischemic reperfusion failure and leukaemia. In formula 1 R1represents 1) a hydrogen atom or 2) a cyano group; R2 and R3 each independently represents 1) a C1-8 alkyl group, 2) a C3-7 cycloalkyl group, 3) a C1-8 alkyl group substituted with a C3-7 cycloalkyl group, 4) a C1-8 alkyl group substituted with 1 to 3 halogen atom(s), 5) a hydrogen atom, 6) a C1-8 alkyl group substituted with a phenyl group, 7) a C1-8 alkyl group substituted with a C1-8 alkoxy group; R4 and R5 each independently represents 1) a hydrogen atom or 2) a C1-8 alkyl group, or R4 and R5 are taken together with the binding carbon atom to represent a C3-7 saturated carbocyclic ring; R6 represents 1) a hydroxyl group, 2) a C1-8 alkoxy group, 3) -NHOH, or 4) a C1-8 alkoxy group substituted with a phenyl group; and m is 0 or an integer of 1 to 4.
申请公布号 NZ524050(A) 申请公布日期 2005.07.29
申请号 NZ20010524050 申请日期 2001.08.09
申请人 ONO PHARMACEUTICAL CO 发明人 NAKAI, HISAO;KISHIKAWA, KATSUYA
分类号 A61P1/00;A61P1/16;A61P3/04;A61P3/10;A61P9/10;A61P11/00;A61P11/06;A61P13/12;A61P17/00;A61P17/06;A61P19/00;A61P19/10;A61P25/16;A61P25/24;A61P25/28;A61P27/14;A61P27/16;A61P29/00;A61P31/04;A61P31/18;A61P35/02;A61P37/06;A61P37/08;A61P43/00;C07D211/22;C07D211/64;(IPC1-7):C07D211/64 主分类号 A61P1/00
代理机构 代理人
主权项
地址